HB 1993 establishes standards and oversight requirements for mental health professionals using artificial intelligence tools in therapy. It directly affects licensed therapists, clinics, and their patients by mandating safety protocols, data privacy safeguards, and regular audits for AI therapy platforms. The bill requires licensing boards to develop enforcement mechanisms, including penalties for non-compliance, and sets criteria for AI tool certification. Referred to the Professional Licensure committee, the bill aims to regulate AI integration while prioritizing patient safety and ethical practice.
SB 329 requires Pennsylvania healthcare professionals (including physicians, physician assistants, and nurse practitioners) to complete at least two hours of continuing education on Lyme disease and related tick-borne illnesses as part of their license renewal. The law mandates that this education cover current research, symptom recognition, diagnostic options, treatment approaches, and prevention strategies, based on evidence from major health organizations. Licensing boards must establish the content within 18 months and seek input from experts, including university researchers. The bill directly affects all licensed healthcare providers in Pennsylvania who must renew their credentials.
Senate Bill 601 proposes an amendment to the Pharmacy Act in Pennsylvania. The bill would permit ivermectin, when intended for human use, to be sold and purchased as an over-the-counter medication. This change would allow individuals to obtain ivermectin without a prescription or consultation with a healthcare professional.
HB 917 repeals Chapter 33 of Pennsylvania's Insurance Code, which previously required insurers offering plans through the state's health insurance exchange to follow specific federal health care law rules regarding abortion coverage. The repealed provisions included a ban on abortion coverage in most plans (except for complications or miscarriage treatment) and an opt-out option for abortion coverage. This bill directly affects insurers and health plans sold through Pennsylvania's health insurance exchange by removing these specific federal compliance requirements. The change eliminates the state's prior restrictions on abortion coverage within qualified health plans.
HR 315 is a non-binding resolution urging Congress and the Department of Veterans Affairs to allow veterans with traumatic brain injury (TBI) or post-traumatic stress disorder (PTSD) to access hyperbaric oxygen therapy. It does not create new law but calls on federal agencies to facilitate this treatment option for veterans. The resolution directly affects veterans diagnosed with TBI or PTSD who may seek this specific therapy. It has been referred to the House Health Committee for further review.
SB 1054 amends the Public School Code of 1949 to require Pennsylvania public schools to maintain opioid antagonists (medicines like naloxone) for emergency use and to train designated staff on their administration. It directly affects schools, students, and school personnel by mandating access to these life-saving medications during opioid overdose emergencies. The key provision establishes that schools must have opioid antagonists available, store them securely, and ensure staff are trained to use them promptly. This policy change updates school health protocols to address the opioid crisis, focusing on immediate response capabilities within school settings.
SB 271 requires Pennsylvania health insurers to cover bariatric surgery and FDA-approved anti-obesity drugs for individuals aged 18 or older. It mandates coverage for treatments meeting standards set by the American Society for Metabolic and Bariatric Surgery or American College of Surgeons, including pre- and post-operative care like nutritional counseling. The law applies to all health insurance policies issued or renewed in Pennsylvania, requiring coverage "to the same extent as for other medically necessary procedures." It specifically abrogates a conflicting regulation (55 Pa. Code § 1121.54(1)) and takes effect 60 days after enactment. This directly affects insurers and Pennsylvania residents seeking obesity-related medical treatments.
HB 1345 would expand Pennsylvania's medical assistance program to cover FDA-approved treatments for menopause symptoms, including hormonal and non-hormonal drugs, devices, and behavioral therapy, for eligible low-income residents. The bill specifically requires coverage for all defined menopausal symptoms - such as hot flashes, bone density loss, and sleep disturbances - as well as treatments for menopause following a hysterectomy. It mandates that the state seek federal approval via a plan amendment or waiver to implement these changes. This policy directly affects enrolled medical assistance recipients experiencing menopausal symptoms, ensuring they receive covered care without additional out-of-pocket costs.
HB 2022 amends the Insurance Company Law of 1921 to require casualty insurance policies to cover scalp cooling systems. The bill directly affects insurance companies and policyholders by mandating coverage for this specific medical technology. However, the provided context does not specify the exact mechanisms for implementation, affected insurance types, or patient eligibility details. The bill was referred to the Insurance committee on November 12, 2025, but no further provisions or impacts are described in the available information. The context lacks sufficient detail to describe key mechanisms or concrete policy changes beyond the title.
This bill establishes a Pennsylvania program that reimburses residents who earn state-recognized emergency medical services (EMS) certifications (such as EMT or paramedic) after paying for training at a Pennsylvania school. Applicants must submit proof of certification and payment, maintain Pennsylvania residency for two years after certification, and apply within 30 days of completing training. The state will cover full certification costs up to a $3 million total appropriation, with payments issued within two months of a complete application. The program ends when the $3 million is fully spent, with no fixed expiration date beyond that.
